A potential role for a quality assurance approach in the management of hypertension

Cardiovascular Journal of South Africa

Volumn , Issue SUPPL. 5, 1996, Pages

  Naidoo, D P ^a  

^a UNIVERSITY OF NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHYLDOPA; NIFEDIPINE; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG USE; HYPERTENSION; QUALITY CONTROL; REVIEW;

EID: 0030417676     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. The Fifth Report of the Joint National Committee. Detection, evaluation and treatment of high blood pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
2. Guidelines Sub-Committee of the WHO-ISH Mild Hypertension Liaison Committee: 1993 Guidelines for the management of mild hypertension. Memorandum from a WHO-ISH meeting. J Hypertens 1993; 11: 905-918.
3. Sever P, Beevers G, Bulpitt C, et al. Management guidelines in essential hypertension: report of the second working group of the British Hypertension Society. BMJ 1993; 306: 983-987.
4. Seedat YK. Clinicopharmacological aspects of hypertension in the black population. Cardiovasc J S Afr 1995; 6: 103-108.